NCT04821479View on ClinicalTrials.gov

Repeated Mesenchymal Stem Cell Injections in ALS

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

December 31, 2020

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

Mesenchymal stem cells (MSC)

Intrathecal injections of autologous bone marrow derived mesenchymal stem cells

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT04821479 - Repeated Mesenchymal Stem Cell Injections in ALS | Biotech Hunter | Biotech Hunter